-transparent.png){kind=logo}
Ornithine transcarbamylase (OCT) is one of the urea-cycle enzymes in mitochondria which is involved in metabolic disorders in man. Reye's syndrome, characterized by encephalopathy and fatty infiltration of the liver, is one of such diseases. During this syndrome a reduction of OCT specific activity was observed, probably due to increased proteolytic degradation or to alteration in the enzyme conformation. It has recently been found that OCT administration to patients with liver disorders, contributes to illness resolution. Since the therapeutic properties of the enzymes are usually related to their structure, this paper reports some findings obtained by spectroscopic measurements on OCT structure and conformation stability in solution.
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
October 1970,
Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
March 1972,
The Journal of biological chemistry,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
November 1982,
Molecular and cellular biochemistry,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
April 1966,
Science (New York, N.Y.),
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
November 1986,
FEBS letters,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
November 1963,
Genetics,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
April 1977,
Pediatric research,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
June 1978,
The Journal of biological chemistry,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
December 1970,
Paediatria Universitatis Tokyo,
E Menegatti, and
F Bortolotti, and
M Guarneri, and
A Scatturin
January 1988,
Journal of inherited metabolic disease,
